Subjects With Mild Alopecia Benefit From Aminexil Clinical 5: Results of a Large International Observational Study
January 2020
in “
IRIS UNIMORE (University of Modena and Reggio Emilia)
”
TLDR Aminexil clinical 5 effectively reduces hair loss and is well-tolerated.
The study assessed the efficacy and tolerability of Aminexil Clinical 5 (AC5) in 527 subjects with mild alopecia. After an average of 82.9 days of use, 87.1% of subjects experienced improved hair loss, with better results in women (91.8%) than men (80.3%). Subject satisfaction was rated at 7.9 out of 10, and 98.6% reported good to very good tolerance. The product's texture was appreciated by 95% of participants. Overall, AC5 was effective in reducing hair loss and was well-received by both subjects and investigators.